PT-141 (Bremelanotide) Peptide Therapy

Service Description

PT-141, also known as bremelanotide, is a cutting-edge peptide therapy designed to enhance sexual desire and performance. Unlike medications that work on blood flow, PT-141 works directly on the brain’s melanocortin receptors—the center of sexual arousal and desire. This makes it uniquely effective for individuals experiencing low libido, arousal disorders, or performance challenges that are not purely vascular in nature. Originally developed for hypoactive sexual desire disorder (HSDD), PT-141 has become a powerful option for patients who feel a disconnect between their mind and body when it comes to intimacy. It can help restore sexual interest, improve arousal, and enhance overall sexual satisfaction. Many patients report a renewed sense of confidence, stronger responsiveness to stimulation, and more fulfilling intimate experiences. PT-141 is administered as a simple subcutaneous injection prior to intimacy. Effects typically begin within a few hours and can last up to 24–48 hours. Because it works through the central nervous system rather than the circulatory system, it can be effective for individuals who have not responded well to traditional sexual performance medications or who want to improve desire rather than just performance. What makes PT-141 truly remarkable is that it supports the psychological and neurological aspects of sexual health—helping patients feel desire again, not just function. It’s a safe, well-tolerated therapy when used under medical supervision and can be an excellent addition to a comprehensive sexual wellness plan. PT-141 offers a modern, science-backed approach to restoring libido, enhancing intimacy, and improving quality of life. Schedule an appointment with one of our trained medical providers today to see if PT-141 therapy is right for you! ***New patient appointments will require a one-time $150 medical assessment fee. Price shown is for 1 vial of PT-141 which will last ~1 month at starting dose. Price may increase depending on patient specific dosing needs and course of treatment.